简介：

简介：Objective:Toobservetheclinicalefficacyofacupuncturetherapyforprostatalgia.Methods:Sixtysubjectswererandomizedintotwogroups:anacupuncturegroupinwhich30casesweretreatedbyacupunctureandamedicationgroupinwhichtheother30casesweretreatedwithherbal

简介：AbstractBackground:To date, there is no effective medicine to treat coronavirus disease 2019 (COVID-19), and the antiviral efficacy of arbidol in the treatment for COVID-19 remained equivocal and controversial. The purpose of this study was to evaluate the efficacy and safety of arbidol tablets in the treatment of COVID-19.Methods:This was a prospective, open-label, controlled and multicenter investigator-initiated trial involving adult patients with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Patients were stratified 1:2 to either standard-of-care (SOC) or SOC plus arbidol tablets (oral administration of 200 mg per time, three times a day for 14 days). The primary endpoint was negative conversion of SARS-CoV-2 within the first week. The rates and 95% confidential intervals were calculated for each variable.Results:A total of 99 patients with laboratory-confirmed SARS-CoV-2 infection were enrolled; 66 were assigned to the SOC plus arbidol tablets group, and 33 to the SOC group. The negative conversion rate of SARS-CoV-2 within the first week in patients receiving arbidol tablets was significantly higher than that of the SOC group (70.3% [45/64] vs. 42.4% [14/33]; difference of conversion rate 27.9%; 95% confidence interval [CI], 7.7%-48.1%; P = 0.008). Compared to those in the SOC group, patients receiving arbidol tablets had a shorter duration of clinical recovery (median 7.0 days vs. 12.0 days; hazard ratio [HR]: 1.877, 95% CI: 1.151-3.060, P = 0.006), symptom of fever (median 3.0 days vs. 12.0 days; HR: 18.990, 95% CI: 5.350-67.410, P < 0.001), as well as hospitalization (median 12.5 days vs. 20.0 days; P < 0.001). Moreover, the addition of arbidol tablets to SOC led to more rapid normalization of declined blood lymphocytes (median 10.0 days vs. 14.5 days; P > 0.05). The most common adverse event in the arbidol tablets group was the elevation of transaminase (5/200, 2.5%), and no one withdrew from the study due to adverse events or disease progression.Conclusions:SOC plus arbidol tablets significantly increase the negative conversion rate of SARS-CoV-2 within the first week and accelerate the recovery of COVID-19 patients. During the treatment with arbidol tablets, we find no significant serious adverse events.Trial registration:Chinese Clinical Trial Registry, NCT04260594, www.clinicaltrials.gov/ct2/show/NCT04260594?term= NCT04260594&draw=2&rank=1

简介：

简介：

简介：震荡器刺激在不同频率的表面下的接口而且电磁波上产生波浪领域的不仅思考和折射。在这篇论文，我们在自发的潜在的地上探讨导致颤动的效果。自发的潜在的领域上的可控制的颤动的效果在真实的地下面被学习地质的条件。试验性的数据证实自发的潜在的领域上的导致颤动的效果确实在领域条件下面存在。在很长时间间隔上监视记录在那里显示出那存在在自发的潜力上的导致颤动的效果的三个信息地区回答。这些是变化信号的地区，极端马厩的地区，和松驰恢复地区。与不同好地点的数据结合了，这被结束在信息地区的异例的变化时间的特征仔细与表面下的液体(油和水)的性质有关。

简介：由使随机化的控制试用为膝骨关节炎(洋槐的一种)观察温暖的刺破的艾灸的临床的效果。

简介：BackgroundDuringprimarypercutaneouscoronaryintervention(PCI),manualthrombectomymayreducedistalembolizationandthusimprovemicrovascularperfusion.Smalltrialshavesuggestedthatthrombectomyimprovessurrogateandclinicaloutcomes,butalargertrialhasreportedconflictingresults.MethodsWerandomlyassigned10,732patientswithST-segmentelevationmyocardialinfarction(STEMI)undergoingprimaryPCItoastrategyofroutineupfrontmanualthrombectomyversusPCIalone.Theprimaryoutcomewasacompositeofdeathfromcardiovascularcauses,recurrentmyocardialinfarction,cardiogenicshock,orNewYorkHeartAssociation(NYHA)classIVheartfailurewithin180days.Thekeysafetyoutcomewasstrokewithin30days.ResultsTheprimaryoutcomeoccurredin347of5033patients(6.9%)inthethrombectomygroupversus351of5030patients(7.0%)inthePCI-alonegroup(hazardratiointhethrombectomygroup,0.99;95%confidenceinterval[CI],0.85to1.15;P=0.86).Theratesofcardiovasculardeath(3.1%withthrombectomyvs.3.5%withPCIalone;hazardratio,0.90;95%CI,0.73to1.12;P=0.34)andtheprimaryoutcomeplusstentthrombosisortarget-vesselrevascularization(9.9%vs.9.8%;hazardratio,1.00;95%CI,0.89to1.14;P=0.95)werealsosimilar.Strokewithin30daysoccurredin33patients(0.7%)inthethrombectomygroupversus16patients(0.3%)inthePCI-alonegroup(hazardratio,2.06;95%CI,1.13to3.75;P=0.02).ConclusionsInpatientswithSTEMIwhowereundergoingprimaryPCI,routinemanualthrombectomy,ascomparedwithPCIalone,didnotreducetheriskofcardiovasculardeath,recurrentmyocardialinfarction,cardiogenicshock,orNYHAclassIVheartfailurewithin180daysbutwasassociatedwithanincreasedrateofstrokewithin30days.

简介：基于同质的平衡方法和试用函数方法，由指数的函数组成的几个试用函数方法被建议并且适用于非线性的分离系统。在符号的计算系统的帮助下，分离非线性的mKdV格子方程的新准确独居的波浪答案，分离非线性(2+1)维的Toda格子方程，Ablowitz-Ladik-lattice系统被构造。方法具有意义寻求准确独居的波浪解决方案到另外的非线性的分离系统。

简介：无

简介：Itisalready20yearssincethepeople’scourtsinChinabegantoacceptandhearadministrativecases.Thankstothecommoneffortsbytheoreticalcircles,legislativeandjudicialdepartments,thesystemofadministrativehearinghasbeenconstantlyimprovedandthecontingentofjudgesforadministrativecaseshasbeenexpanding.Thesystemhasplayedanincreasinglyimportantroleinsafeguardingsocialstability,ensuringlong-termpeaceandsecurity,protectingthelawfulrightsandinterestsofthecitizensandenhancingtheirawarenessoflawandrights.

简介：无

简介：实验可能性的途径基于constrains被建议到预告测验柱子试用，我们构造它总结所有给定的信息。作者获得有标准摆平chi的限制分布的一个木头实验的可能性的比率测试统计数值。因此在做推论，没有需要明确地估计变化，并且推论的过程更容易实现。模拟结果证明这份报纸的途径由于信息的足够、适当的使用与ANCOVAII相比是更有效的。

简介：无

简介：Detainees’rightsinpre-trialdetentionhousesareameansofassessingacountry’shumanrightsprotection.Asalegalfacilityforcarryingoutcriminaldetention,apre-trialdetentionhouseshouldremainneutralandsafeguarddetainees’substantiveandproceduralrights.Itshouldbeanimportantbaseforthecountrytorespectandprotecthumanrights.Atthemacrolevel,protectingdetainees’rightscomprisestwoaspects:1)proceduralrights,regardingwhichtheprincipleofpresumptionofinnocenceshouldbeapplied;and2)detaineetreatment,regardingwhichtheprincipleofsocializationshouldbeapplied.AtthecurrentstageofChina’srightsprotectionsituation,Chinashouldimprovedetainees’rights,suchastherighttohaveanindividualbed,therightstohealthcareandreligiousfreedom,rulesregardingtheuseoflegirons,andtransparencyandindependentmonitoringmechanisms.

简介：

简介：系在的系统为钻在的半能沉入水中的钻塔起一个重要作用深海。详细分析在进行了很好在2009在华南海在一个深海的地点钻的试用的一个半能沉入水中的钻塔的绳索上被执行。钻塔是30岁并且与457m的设计的最大的操作的水深度有一个浅平台。后面的系在分析，一个系在的图案被给那要求钻塔原版绳索系统升级。升级包括了几革新，例如安装八个更大的锚，即代替原来的锚并且插入一另外有存在的链的钢电线的600m。所有这些被做为在职务要保持进行在476m的水深度钻的钻塔提高钻塔的系在的能力。钻的全面持续时间是50天和证明在当它在华南海正在钻试用很好时，达到使钻塔静止的目标有效的升级的绳索系统。这个成功的运动证明一个更旧的半能沉入水中的钻塔能雇用在小心的设计并且到原来的绳索系统的合适的升级和修正以后在深水里钻。

简介：前列腺癌症预防选拔赛(PCPT)是泌尿学的领域里的精液的研究。在它的起始的出版以后的超过10年，从这试用的更新的数据继续塑造我们前列腺癌症的理解。一旦想了在正常范围，在从PCPT的主要调查结果之中是前列腺癌症在有前列腺特定的抗原(PSA)的人是普通的示范，1finasteride阻止良性的prostatic肥大的发展，2它而且增加PSA3和数字直肠的examination.4的敏感PCPT帮助建立在可勃起的机能障碍和心血管的疾病之间的连接，5并且也许，最重要地，finasteride表明了25%相对风险reduc

简介：

简介：